Is the FDA Pausing More Cancer Trials? It's Hard to Tell Is the FDA Pausing More Cancer Trials? It's Hard to Tell
Clinical trial holds delay therapies getting to market and may be on the rise in oncology. But there ' s a lot the public doesn ' t know about how often these holds happen and why.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 24, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19
Group sales grew by 2%1 at constant exchange rates (CER) (-6% in CHF), driven by the strong growth of newer medicines and diagnostics. Excluding COVID-19-related products, sales increased by 7%. Going forward, there will be no further material impact of COVID-19 sales declineDue to the appreciation of the Swiss franc against most currencies,saleswere 6% lower when reported in CHFPharmaceuticals Divisionbase business2 grew by 7%, driven by strong sales of medicines to treat severe diseases, such as Vabysmo (eye diseases), Phesgo (breast cancer), Ocrevus (multiple sclerosis), Polivy (blood cancer) and Hemlibra (haemophilia A...
Source: Roche Investor Update - April 24, 2024 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19
Group sales grew by 2%1 at constant exchange rates (CER) (-6% in CHF), driven by the strong growth of newer medicines and diagnostics. Excluding COVID-19-related products, sales increased by 7%. Going forward, there will be no further material impact of COVID-19 sales declineDue to the appreciation of the Swiss franc against most currencies,saleswere 6% lower when reported in CHFPharmaceuticals Divisionbase business2 grew by 7%, driven by strong sales of medicines to treat severe diseases, such as Vabysmo (eye diseases), Phesgo (breast cancer), Ocrevus (multiple sclerosis), Polivy (blood cancer) and Hemlibra (haemophilia A...
Source: Roche Media News - April 24, 2024 Category: Pharmaceuticals Source Type: news
Clinical practice LCS program finds more disease than NLST
Over a five-year period, a clinical practice lung cancer screening program at Duke University Medical Center in Durham, NC, found more disease than did the National Lung Screening Trial (NLST), researchers have reported.
The program showed a higher rate of lung cancer compared to the NLST’s, at 3.4% versus 2.4%. It also found more stage IV disease, wrote a team led by Kyle Lafata, PhD. The results were published April 23 in the Journal of the American College of Radiology.
“As LCS uptake increases, monitoring and tracking screening outcomes in clinical practice settings is key to high-quality screening and success,â€...
Source: AuntMinnie.com Headlines - April 24, 2024 Category: Radiology Authors: Kate Madden Yee Tags: CT Chest Radiology Source Type: news
Voiant and Thirona enter commercial partnership
Waltham, MA-based clinical trial imaging services provider Voiant and Dutch AI software developer Thirona have entered a global commercial partnership.
The partnership combines Voiant's expertise in supporting clinical trials in pulmonary drug and treatment development with Thirona's AI software for lung image analysis. The companies will offer an integrated platform designed to deliver precise imaging endpoints in trials.
Voiant's network includes more than 400 certified clinical trial sites, while Thirona's software products include algorithms for chest CT image analysis. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 24, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
Ethiopia: Promising Patient-Friendly Oral Drug Against Visceral Leishmaniasis Enters Phase II Clinical Trial in Ethiopia
[WHO] The new molecule has the potential to revolutionize treatment for the deeply neglected and hard-to-treat disease, as the Eastern Africa region charts the way to its elimination. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 24, 2024 Category: African Health Tags: East Africa Ethiopia External Relations Health and Medicine International Organizations and Africa Source Type: news
Argenica Begins Key Stroke Treatment Trials
Argenica Therapeutics Ltd (AU:AGN) has released an update. Argenica Therapeutics Ltd has initiated Phase 2 clinical trials for its stroke treatment...#agn #phase2 (Source: Reuters: Health)
Source: Reuters: Health - April 24, 2024 Category: Consumer Health News Source Type: news
Clinical Trials in Australia: Recommendations for Maximizing Collaboration between China and Australia, Upcoming Webinar Hosted by Taimei Technology
In this free webinar, attendees will gain insights into the clinical trial landscapes in China and Australia and discover practical strategies for maximizing collaboration and ensuring successful outcomes. This includes identifying common areas of interest, leveraging each other's... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 23, 2024 Category: Pharmaceuticals Tags: FVT Source Type: news
Key Considerations for Cell Therapy Trials Beyond Oncology, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn the essential infrastructure requirements necessary for clinical sites to effectively manage cell therapy products in non-oncology clinical trials. Attendees will learn the key considerations in patient selection criteria for non-oncology cell therapy trials,... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 23, 2024 Category: Pharmaceuticals Tags: FVT Source Type: news
Society for Immunotherapy of Cancer Publishes Recommendations on Optimal Intratumoral Immunotherapy Clinical Trial (IICT) Design
The Society for Immunotherapy of Cancer (SITC) is pleased to announce the publication of a new manuscript "Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from pre-malignant to metastatic disease" in the Journal for... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 23, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news
Breast Milk Enema Helps Preterm Infants Pass Meconium
(MedPage Today) -- A breast milk enema resulted in faster meconium evacuation and a shorter time to enteral feeding compared with a saline enema, a randomized clinical trial in a Chinese hospital showed.
Among 286 preterm infants, those who received... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - April 22, 2024 Category: Gastroenterology Source Type: news
Krystal Biotech moves to next step in clinical trial
Krystal Biotech has announced the first patient has joined a trial for its inhaled treatment for a solid lung cancer tumor. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 22, 2024 Category: Pharmaceuticals Authors: Paul J. Gough Source Type: news
Universal Ibogaine Targets Fundraising for Clinical Trials
https://www.tipranks.com/news/company-announcements/universal-ibogaine-targets-fundraising-for-clinical-trials?utm_source=biztoc.com&utm_medium=referral (Source: Reuters: Health)
Source: Reuters: Health - April 22, 2024 Category: Consumer Health News Source Type: news
Solving unmet needs in GLP1 cardiometabolic clinical trials: novel approaches to digital data capture & amp; patient retention (Upcoming Xtalks webinar hosted by Clinical ink)
In this free webinar, attendees will gain insights into current recommendations for capturing key endpoint data in clinical trials of therapies for diabetes, weight management, NASH, and MASH. Panelists will discuss the complexity of digital systems required to continuously monitor... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 22, 2024 Category: Pharmaceuticals Tags: FVT TDS Source Type: news
Teaching children pedestrian safety in virtual reality via smartphone: a noninferiority randomized clinical trial - Schwebel DC, Johnston A, McDaniel D, Severson J, He Y, McClure LA.
OBJECTIVE: To evaluate whether child pedestrian safety training in a smartphone-based virtual reality (VR) environment is not inferior to training in a large, semi-immersive VR environment with demonstrated effectiveness. METHODS: Five hundred 7- a... (Source: SafetyLit)
Source: SafetyLit - April 22, 2024 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
